These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8342183)

  • 1. Treatment of acute cortical infarct with intravenous glycerol. A double-blind, placebo-controlled randomized trial.
    Yu YL; Kumana CR; Lauder IJ; Cheung YK; Chan FL; Kou M; Fong KY; Cheung RT; Chang CM
    Stroke; 1993 Aug; 24(8):1119-24. PubMed ID: 8342183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial.
    Yu YL; Kumana CR; Lauder IJ; Cheung YK; Chan FL; Kou M; Chang CM; Cheung RT; Fong KY
    Stroke; 1992 Jul; 23(7):967-71. PubMed ID: 1615546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
    Cooperative Group for Reassessment of Defibrase
    Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with 10% glycerin in acute ischemic cerebral infarct. Doubleblind study].
    Friedli W; Imbach P; Ghisleni-Steinegger S; Schwarz C; Maire P
    Schweiz Med Wochenschr; 1979 May; 109(20):737-42. PubMed ID: 451497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of intravascular haemolysis during treatment of acute stroke with intravenous glycerol.
    Kumana CR; Chan GT; Yu YL; Lauder IJ; Chan TK; Kou M
    Br J Clin Pharmacol; 1990 Mar; 29(3):347-53. PubMed ID: 2310658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
    Lyden PD; Shuaib A; Lees KR; Davalos A; Davis SM; Diener HC; Grotta JC; Ashwood TJ; Hardemark HG; Svensson HH; Rodichok L; Wasiewski WW; Ahlberg G;
    Stroke; 2007 Aug; 38(8):2262-9. PubMed ID: 17569876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous glycerol in cerebral infarction: a controlled 4-month trial.
    Fawer R; Justafré JC; Berger JP; Schelling JL
    Stroke; 1978; 9(5):484-6. PubMed ID: 360495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.
    Diener HC; Hacke W; Hennerici M; Rådberg J; Hantson L; De Keyser J
    Stroke; 1996 Jan; 27(1):76-81. PubMed ID: 8553408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind randomised trial of intravenous glycerol in acute stroke.
    Bayer AJ; Pathy MS; Newcombe R
    Lancet; 1987 Feb; 1(8530):405-8. PubMed ID: 2880214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
    Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
    J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
    Clark WM; Albers GW; Madden KP; Hamilton S
    Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.
    Yamaguchi T; Sano K; Takakura K; Saito I; Shinohara Y; Asano T; Yasuhara H
    Stroke; 1998 Jan; 29(1):12-7. PubMed ID: 9445321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy with streptokinase in acute ischemic stroke.
    ; Hommel M; Cornu C; Boutitie F; Boissel JP
    N Engl J Med; 1996 Jul; 335(3):145-50. PubMed ID: 8657211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
    Meretoja A; Churilov L; Campbell BC; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM
    Int J Stroke; 2014 Jun; 9(4):519-24. PubMed ID: 23981692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind trial of glycerol therapy in early stroke.
    Larsson O; Marinovich N; Barber K
    Lancet; 1976 Apr; 1(7964):832-4. PubMed ID: 56650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.